US drugmaker AbbVie has announced two updates for Canadians living with ulcerative colitis (UC) in relation to its drug ...

US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) says the American medicines regulator has extended its expedited re-review of ...

Cantor Fitzgerald issued a note showing that this week saw a broad-based bounce back in GLP-1 prescription activity after ...

China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ Pecondle (picankibart injection), a ...

The 2025 ISPE Pharma 4.0 Conference brings together global pharmaceutical and biopharmaceutical professionals to explore the ...

French vaccine developer Valneva (Nasdaq: VALN) plans to close its Nantes site and consolidate all French activities in Lyon ...

Zhongmou Therapeutics, a Chinese genomic medicine company focused on restoring vision through gene and optogenetic therapies, ...

The European Association of Hospital Pharmacists (EAHP) released the results of its new Shortages Survey, assessing and ...

Dr Pejvack Motlagh has been appointed as the new chief medical officer of French biopharma Genfit, a French biotech company ...

Australian biotech Cartherics has appointed Dr Ian Nisbet as chief executive (CEO) as part of a planned leadership transition ...

Eisai (TYO: 4523) has submitted a new drug application in Japan for a subcutaneous autoinjector version of Leqembi (lecanemab ...

NEC Corporation and Otsuka subsidiary Taiho Pharmaceutical have signed a three-party joint research agreement aimed at ...